Table 2.
Pregnancy outcomes of total patients according to AMH level
| Outcomes | Serum AMH, ng/mL | P-value | ||
|---|---|---|---|---|
| ≤ 2.25 (n = 746) | 2.25–5.71 (n = 1486) | > 5.71 (n = 741) | ||
| Implantation rate | 0.42 ± 0.41a,b | 0.50 ± 0.43 | 0.53 ± 0.42 | < 0.0011 |
| Clinical pregnancy rate | 58.8% (439/746)a,b | 64.7% (961/1486)b | 69.9% (518/741) | < 0.0012 |
| Miscarriage rate | 18.0% (79/439)c | 12.9% (124/961) | 12.7% (66/518) | 0.0242 |
| Early miscarriage rate | 13.4% (59/439)d | 9.7% (93/961) | 8.3% (43/518) | 0.0252 |
| Late miscarriage rate | 4.6% (20/439) | 3.2% (31/961) | 4.4% (23/518) | 0.3532 |
| Live birth rate | 47.6% (354/743)a,b | 55.2% (814/1474) | 59.5% (436/733) | < 0.0012 |
| No. of live babies delivered | 0.0072 | |||
| 1 | 75.7% (268/354)e | 69.8% (568/814) | 65.4% (285/436) | |
| ≥ 2 | 24.3% (86/354) | 30.2% (246/814) | 34.6% (151/436) | |
Note: Continuous variables: 1Kruskal-Wallis test followed by a post-hoc pairwise comparison. Categorical variables: 2Chi-square test followed by post-hoc Bonferroni correction
aP < 0.001, statistically significant differences from average-AMH group
bP < 0.001, statistically significant differences from high-AMH group
cP < 0.05, statistically significant differences from average-AMH group
dP < 0.05, statistically significant differences from high-AMH group
eP < 0.01, statistically significant differences from high-AMH group